- Home
- CNTX vs FGB Comparison
CNTX vs FGB Comparison
Compare CNTX & FGB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CNTX
- FGB
- Stock Information
- Founded
- CNTX 2015
- FGB 2007
- Country
- CNTX United States
- FGB United States
- Employees
- CNTX N/A
- FGB N/A
- Industry
- CNTX Biotechnology: Pharmaceutical Preparations
- FGB Finance/Investors Services
- Sector
- CNTX Health Care
- FGB Finance
- Exchange
- CNTX Nasdaq
- FGB Nasdaq
- Market Cap
- CNTX 77.2M
- FGB 61.9M
- IPO Year
- CNTX 2021
- FGB N/A
- Fundamental
- Price
- CNTX $0.96
- FGB $4.42
- Analyst Decision
- CNTX Strong Buy
- FGB
- Analyst Count
- CNTX 5
- FGB 0
- Target Price
- CNTX $6.70
- FGB N/A
- AVG Volume (30 Days)
- CNTX 1.1M
- FGB 53.0K
- Earning Date
- CNTX 11-06-2024
- FGB 01-01-0001
- Dividend Yield
- CNTX N/A
- FGB 8.92%
- EPS Growth
- CNTX N/A
- FGB N/A
- EPS
- CNTX N/A
- FGB N/A
- Revenue
- CNTX N/A
- FGB N/A
- Revenue This Year
- CNTX N/A
- FGB N/A
- Revenue Next Year
- CNTX N/A
- FGB N/A
- P/E Ratio
- CNTX N/A
- FGB N/A
- Revenue Growth
- CNTX N/A
- FGB N/A
- 52 Week Low
- CNTX $0.89
- FGB $2.85
- 52 Week High
- CNTX $2.75
- FGB $3.74
- Technical
- Relative Strength Index (RSI)
- CNTX 38.22
- FGB 63.48
- Support Level
- CNTX $0.92
- FGB $4.25
- Resistance Level
- CNTX $1.05
- FGB $4.32
- Average True Range (ATR)
- CNTX 0.13
- FGB 0.10
- MACD
- CNTX 0.01
- FGB 0.01
- Stochastic Oscillator
- CNTX 17.78
- FGB 83.87
About CNTX Context Therapeutics Inc.
Context Therapeutics Inc is a clinical-stage biopharmaceutical company advancing medicines for solid tumors. The development team is advancing a pipeline of innovative therapies with a primary focus on treating female, hormone-dependent cancer, including breast, ovarian, and endometrial cancer. The company's preclinical program, CTIM-76, is an anti-Claudin 6 ("CLDN6") x anti-CD3 bispecific antibody ("bsAb") that is intended to redirect T-cell-mediated lysis toward malignant cells expressing CLDN6.
About FGB First Trust Specialty Finance and Financial Opportunities Fund
First Trust Specialty Fnc & Fncl Oppor is a United States-based closed-end management investment company. The Fund's primary investment objective is to seek a high level of current income. It seeks a positive total return as a secondary objective. The Fund seeks to achieve its investment objectives by investing at least 80% of its Managed Assets in a portfolio of securities of specialty finance and other financial companies.